Polymeric nanoparticles

Nanocarriers with various compositions and biological properties have been extensively applied for in vitro/in vivo drug and gene delivery. The family of nanocarriers includes polymeric nanoparticles, lipid-based carriers (liposomes/micelles), dendrimers, carbon nanotubes, and gold nanoparticles (nanoshells/nanocages). Among different delivery systems, polymeric carriers have several properties such as: easy to synthesize, inexpensive, biocompatible, biodegradable, non-immunogenic, non-toxic, and water soluble. In addition, cationic polymers seem to produce more stable complexes led to a more protection during cellular trafficking than cationic lipids. Nanoparticles often show significant adjuvant effects in vaccine delivery since they may be easily taken up by antigen presenting cells (APCs). Natural polymers such as polysaccharides and synthetic polymers have demonstrated great potential to form vaccine nanoparticles. The development of new adjuvants or delivery systems for DNA and protein immunization is an expanding research field. This review describes polymeric carriers especially PLGA, chitosan, and PEI as vaccine delivery systems.

[1]  Y. Li,et al.  Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. , 2006, Vaccine.

[2]  A. Bolcato-Bellemin,et al.  Systemic Delivery of DNA or siRNA Mediated by Linear Polyethylenimine (L-PEI) Does Not Induce an Inflammatory Response , 2008, Pharmaceutical Research.

[3]  J. Schlom,et al.  Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12 , 2010, Journal of immunotherapy.

[4]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[5]  Nikolai Petrovsky,et al.  Technologies for enhanced efficacy of DNA vaccines , 2012, Expert review of vaccines.

[6]  Jian Zhang,et al.  Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. , 2002, Human gene therapy.

[7]  Jun Li,et al.  Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. , 2010, Biomaterials.

[8]  L. Seymour,et al.  Formulation of a microparticle carrier for oral polyplex-based DNA vaccines. , 2004, Biochimica et biophysica acta.

[9]  M. Davis,et al.  Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. , 2001, Current opinion in molecular therapeutics.

[10]  J. Lai,et al.  Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications , 2012, Front. Physio..

[11]  Daniel G. Anderson,et al.  Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Bhaskaran,et al.  Recent trends in vaccine delivery systems: A review , 2011, International journal of pharmaceutical investigation.

[13]  Y. Tabata,et al.  Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity , 2012, International journal of nanomedicine.

[14]  Vladimir P Torchilin,et al.  Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. , 2008, Biopolymers.

[15]  R. Mulherkar.  Gene Therapy for Cancer: Is there Light at the End of the Tunnel? , 2012 .

[16]  B. Aggarwal,et al.  Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. , 2012, Current drug targets.

[17]  Yves-Jacques Schneider,et al.  Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[19]  J. Palefsky,et al.  Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Yuan Yang,et al.  Application of Ferriferous Oxide Modified by Chitosan in Gene Delivery , 2012, Journal of drug delivery.

[21]  Jessica B. Graham.  Co-delivery of cationic polymers and adenovirus in immunotherapy of prostate cancer , 2010 .

[22]  Daniel G. Anderson,et al.  Polymeric Materials for Gene Delivery and DNA Vaccination , 2009, Advanced materials.

[23]  C. Crum,et al.  Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. , 2003, American journal of obstetrics and gynecology.

[24]  Á. González-Fernández,et al.  Chitosan-based nanoparticles for improving immunization against hepatitis B infection. , 2010, Vaccine.

[25]  B. Liu,et al.  Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  Mansoor M Amiji,et al.  An overview of condensing and noncondensing polymeric systems for gene delivery. , 2007, CSH protocols.

[27]  R. Muzzarelli.  Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers , 2010, Marine drugs.

[28]  Francisco A. R. Garcia,et al.  ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial , 2004, Obstetrics and gynecology.

[29]  Anthony E. Gregory,et al.  Vaccine delivery using nanoparticles , 2013, Front. Cell. Infect. Microbiol..

[30]  M. Geng,et al.  Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 , 2013, Molecules.

[31]  W. Tiyaboonchai.  CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY , 2003 .

[32]  G. Zhai,et al.  Advances in clinical study of curcumin. , 2013, Current pharmaceutical design.

[33]  F. Galvano,et al.  Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. , 2013, Journal of biological regulators and homeostatic agents.

[34]  M. Houghton,et al.  Cationic microparticles are a potent delivery system for a HCV DNA vaccine. , 2004, Vaccine.

[35]  Ernst Wagner,et al.  Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Anna‐Karin Roos.  Delivery of DNA vaccines against cancer , 2006 .

[37]  J. Lisziewicz,et al.  DermaVir: a novel topical vaccine for HIV/AIDS. , 2005, The Journal of investigative dermatology.

[38]  Ravi R. Patel,et al.  Chitosan mediated targeted drug delivery system: a review. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[39]  E. Hébert.  Improvement of exogenous DNA nuclear importation by nuclear localization signal‐bearing vectors: a promising way for non‐viral gene therapy? , 2003, Biology of the cell.

[40]  Jordan Jamieson Green,et al.  Enhanced polymeric nanoparticles for gene delivery , 2007 .

[41]  M. Zink,et al.  Dose-Dependent Protection against or Exacerbation of Disease by a Polylactide Glycolide Microparticle-Adsorbed, Alphavirus-Based Measles Virus DNA Vaccine in Rhesus Macaques , 2008, Clinical and Vaccine Immunology.

[42]  Murali M. Yallapu,et al.  Curcumin nanomedicine: a road to cancer therapeutics. , 2013, Current pharmaceutical design.

[43]  H. Fenniri,et al.  Nanotechnology-based drug delivery systems , 2007, Journal of occupational medicine and toxicology.

[44]  Na Zhang,et al.  Cationic polymer optimization for efficient gene delivery. , 2010, Mini reviews in medicinal chemistry.

[45]  Victor M. Castaño,et al.  Polymeric and Ceramic Nanoparticles in Biomedical Applications , 2012 .

[46]  Gerrit Borchard,et al.  Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. , 2004, Vaccine.

[47]  F. Alexis,et al.  Covalent Attachment of Low Molecular Weight Poly(ethylene imine) Improves Tat Peptide Mediated Gene Delivery , 2006 .

[48]  S. Kasturi,et al.  Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. , 2005, Biomaterials.

[49]  Marie Carrière,et al.  NLS bioconjugates for targeting therapeutic genes to the nucleus. , 2003, Advanced drug delivery reviews.

[50]  Junfeng Zhang,et al.  Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. , 2013, Biomaterials.

[51]  Jing Xu,et al.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery. , 2012, International journal of pharmaceutics.

[52]  C. Gamazo,et al.  Synthetic particulate antigen delivery systems for vaccination , 2005 .

[53]  G. Borchard.  Chitosans for gene delivery. , 2001, Advanced drug delivery reviews.

[54]  Pascal Viel,et al.  Synthesis of Thin and Highly Conductive DNA‐Based Palladium Nanowires , 2008 .

[55]  Junfeng Zhang,et al.  The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. , 2010, Biomaterials.

[56]  Wim E Hennink,et al.  Biodegradable polymers as non-viral carriers for plasmid DNA delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[57]  D. Montefiori,et al.  Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins , 2005, Journal of Virology.

[58]  A. Mitra,et al.  Chitosan Microspheres in Novel Drug Delivery Systems , 2011, Indian journal of pharmaceutical sciences.

[59]  T. Nandedkar.  Nanovaccines: recent developments in vaccination , 2009, Journal of Biosciences.

[60]  L. Lunsford,et al.  Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. , 2002, Vaccine.

[61]  A. Coombes,et al.  Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. , 1996, Vaccine.

[62]  T. Cheng,et al.  Therapeutic potential of chitosan and its derivatives in regenerative medicine. , 2006, The Journal of surgical research.

[63]  Kristian Berg,et al.  Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways. , 2012, International journal of biological macromolecules.

[64]  Ann Logan,et al.  Barriers to Gene Delivery Using Synthetic Vectors. , 2005, Advances in genetics.

[65]  Yuquan Wei,et al.  Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A , 2011, International journal of nanomedicine.

[66]  Vladimir P Torchilin,et al.  Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Peter H Lin,et al.  Current advances in research and clinical applications of PLGA-based nanotechnology , 2009, Expert review of molecular diagnostics.

[68]  A. Maitra,et al.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. , 2013, Molecular pharmaceutics.

[69]  A. Bolhassani,et al.  The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen , 2009, Drug delivery.

[70]  S. Nair,et al.  Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. , 2013, Current pharmaceutical design.

[71]  Ling Li,et al.  Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. , 2013, International journal of pharmaceutics.

[72]  G. Lukács,et al.  Intracellular barriers to non-viral gene transfer. , 2002, Current gene therapy.

[73]  J. Engbersen,et al.  Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[74]  U. Ramstedt,et al.  Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. , 2004, Clinical immunology.

[75]  S. Parveen,et al.  Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. , 2011, European journal of pharmacology.

[76]  Tae Woo Kim,et al.  Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity , 2009, Clinical & Experimental Metastasis.

[77]  Mark E. Davis,et al.  Non-viral gene delivery systems. , 2002, Current opinion in biotechnology.

[78]  S. Chong,et al.  Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery. , 2013, International journal of pharmaceutics.

[79]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[80]  Jun Jie Wang,et al.  Recent advances of chitosan nanoparticles as drug carriers , 2011, International journal of nanomedicine.

[81]  L. Kwak,et al.  Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[82]  Wenhui Wu,et al.  Degradable copolymer based on amphiphilic N-octyl-N-quatenary chitosan and low-molecular weight polyethylenimine for gene delivery , 2012, International journal of nanomedicine.

[83]  T. Tencomnao,et al.  The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells. , 2012, Carbohydrate polymers.

[84]  Wei R. Chen,et al.  Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine , 2013, Clinical & developmental immunology.

[85]  Yun-Jaie Choi,et al.  Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review , 2012, International journal of nanomedicine.

[86]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .